CANCER VOICES AUSTRALIA v MYRIAD GENETICS INC [2013] FCA 65:Should gene patent monopolies trump public health?
| dc.contributor.author | Vines, Tim | en_AU |
| dc.contributor.author | Faunce, Thomas | en_AU |
| dc.date.accessioned | 2015-12-08T22:45:21Z | |
| dc.date.issued | 2013 | |
| dc.date.updated | 2015-12-08T10:52:24Z | |
| dc.description.abstract | At a time when the double mastectomy of Angelina Jolie has highlighted the importance of genetic testing for breast cancer, the Federal Court�s decision in Cancer Voices Australia v Myriad Genetics Inc [2013] FCA 65 has clarified that, for now at least, isolated DNA and RNA can constitute a patentable invention under s 18(1)(a) of the Patents Act 1990 (Cth). This is a significant decision for companies seeking to secure patents over DNA and genetic material, whether isolated or not. This column critically examines this case in the context of parallel legal action currently underway in the United States. It also reviews it with regard to political and bureaucratic inaction in Australia (much of which relies upon an overly restrictive interpretation of the High Court decision in National Research Development Corp v Commissioner of Patents (1959) 102 CLR 252) that has compromised the setting of cost-effective public health limits on patentable subject matter concerning the human genome. | |
| dc.identifier.issn | 1320-159X | |
| dc.identifier.uri | http://hdl.handle.net/1885/37794 | |
| dc.provenance | The permission to archive the version was archived in ERMS2988179. This article was first published by Thomson Reuters in the Journal of Law and Medicine and should be cited as "Vines, Timothy, and Thomas Alured Faunce. "Cancer Voices Australia v Myriad Genetics Inc [2013] FCA 65: Should Gene Patent Monopolies Trump Public Health?." (2013).". For all subscription inquiries please phone, from Australia: 1300 304 195, from Overseas: +61 2 8587 7980 or online at legal.thomsonreuters.com.au/search. The official PDF version of this article can also be purchased separately from Thomson Reuters at http://sites.thomsonreuters.com.au/journals/subscribe-or-purchase | en_AU |
| dc.publisher | The Law Book Company | |
| dc.rights | Copyright Lawbook Co. This publication is copyright. Other than for the purposes of and subject to the conditions prescribed under the Copyright Act 1968 (Cth), no part of it may in any form or by any means (electronic, mechanical, microcopying, photocopying, recording or otherwise) be reproduced, stored in a retrieval system or transmitted without prior written permission. Enquiries should be addressed to Thomson Reuters (Professional) Australia Limited. | en_AU |
| dc.source | Journal of Law and Medicine | |
| dc.source.uri | http://ssrn.com/abstract=2333294 | |
| dc.title | CANCER VOICES AUSTRALIA v MYRIAD GENETICS INC [2013] FCA 65:Should gene patent monopolies trump public health? | |
| dc.type | Journal article | |
| dcterms.accessRights | Open Access | en_AU |
| local.bibliographicCitation.lastpage | 758 | |
| local.bibliographicCitation.startpage | 747 | |
| local.contributor.affiliation | Vines, Tim, Civil Liberties Australia | |
| local.contributor.affiliation | Faunce, Thomas, ANU College of Law, ANU | |
| local.contributor.authoruid | Faunce, Thomas, u9705219 | |
| local.description.notes | Imported from ARIES | |
| local.identifier.absfor | 180111 - Environmental and Natural Resources Law | |
| local.identifier.absseo | 859805 - Management of Solid Waste from Energy Activities | |
| local.identifier.absseo | 859801 - Management of Gaseous Waste from Energy Activities (excl. Greenhouse Gases) | |
| local.identifier.ariespublication | u4712283xPUB153 | |
| local.identifier.citationvolume | 20 | |
| local.type.status | Published Version |
Downloads
Original bundle
1 - 1 of 1
Loading...
- Name:
- 01_Vines_CANCER_VOICES_AUSTRALIA_v_2013.pdf
- Size:
- 113.33 KB
- Format:
- Adobe Portable Document Format